Shire
SHP
Delayed London Stock Exchange - 04/25 05:35:11 pm
3820GBp
-2.8%
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Develops and markets medicines for patients with rare diseases

Shire Plc is a biopharmaceutical company.

It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.

The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.

Shire was founded in 1986 and is headquartered in Dublin, Ireland.

Number of employees : 23 044 persons.
Sales per Businesses
20162017
GBP
(in Million)
%GBP
(in Million)
%
Product8,10295.9%11,22095.3%
Royalties and Other Revenues380.204.5%--
Royalties--348.193%
Other Revenue--204.451.7%
Sales per Regions
20162017
GBP
(in Million)
%GBP
(in Million)
%
United States5,70767.6%7,48763.6%
Rest of World2,74532.5%4,24236%
Ireland30.960.4%43.100.4%
Austria----
Shareholders
- The Vanguard Group, Inc.3.19%
- Norges Bank Investment Management2.45%
- Capital Research & Management Co. (World Investors)2.34%
- Legal & General Investment Management Ltd.2.32%
- Lazard Asset Management LLC2.01%
- Glenview Capital Management LLC1.98%
Managers
- Chief Executive Officer & Executive Director :
    Flemming ěrnskov
- Non-Executive Chairman :
    Susan Kilsby
- Chief Financial Officer & Director :
    Thomas J. W. Dittrich
- Chief Medical Officer :
    Howard Mayer
- Head-Technical Operations :
    Matthew Walker
- Chief Scientific Officer :
    Andreas Busch
- Independent Non-Executive Director :
    David Ginsburg
- Independent Non-Executive Director :
    Anne Minto
- Senior Independent Director :
    William Burns
- Independent Non-Executive Director :
    Steven Gillis
Company contact information
22 Grenville street
JE4 8PX Saint Helier, Jersey, Channel Islands
United Kingdom

Phone : +44 (0)12 56 894 160
Fax : +44
Internet : http://www.shire.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, Nasdaq 100, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  JE00B2QKY057
- Bloomberg Code :  SHP
- Reuters Code :  SHP.L
- Datastream Code :  SHP
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision